Literature DB >> 20071492

Single lysophosphatidylcholine components exhibit adjuvant activities in vitro and in vivo.

Guillaume Bach1, Laure Perrin-Cocon, Estelle Gerossier, Aurélie Guironnet-Paquet, Vincent Lotteau, Geneviève Inchauspé, Anne Fournillier.   

Abstract

Improving vaccine immunogenicity by developing new adjuvant formulations has long been a goal of vaccinologists. It has previously been shown that a natural mix of lysophosphatidylcholine (LPC) from chicken eggs promotes mature dendritic cell (DC) generation in vitro and primes antigen-specific immune responses in mice. In the present study, we dissected the adjuvant potentials of five individual LPC components found in the chicken egg mixture. In vitro analyses of the impact of the individual components on the maturation of human DCs were performed by means of phenotypic analysis, chemokine secretion analysis, and analysis of the ability of mature DC to stimulate T lymphocytes. Two components, C16:0-LPC and C18:0-LPC, were identified to be capable of the upregulation of expression of CD86, HLA-DR, and CD40 on in vitro-cultured monocyte-derived DCs from healthy donors. Both induced the release of chemokines to high concentrations (macrophage inflammatory protein 1, monocyte chemoattractant protein 1) or moderate concentrations (interleukin-8 [IL-8], gamma interferon-inducible protein 10). In addition, C16:0-LPC engaged naïve T cells to produce gamma interferon. This suggests that C16:0-LPC and C18:0-LPC have the capacity to promote, at least in vitro, a Th1-oriented response. The intravenous injection of C16:0-LPC or C18:0-LPC into mice resulted in the detectable secretion of IL-6 and IL-5 in sera. Both LPC components were tested for their capacities to act as adjuvants for two selected immunogens: the hepatitis B virus surface antigen and the hepatitis C virus NS3 helicase. The secretion of specific IgG1 was observed with either or both C16:0-LPC and C18:0-LPC, depending on the immunogen tested, and was observed at an efficiency comparable to that of alum. These data identify C16:0-LPC and C18:0-LPC as the active components of the LPC natural mixture. Although discrepancies between the results of the in vitro and in vivo analyses existed, studies with animals suggest that these components can trigger significant and specific humoral-mediated immunity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071492      PMCID: PMC2837973          DOI: 10.1128/CVI.00420-09

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  22 in total

Review 1.  Aluminium adjuvants--in retrospect and prospect.

Authors:  Erik B Lindblad
Journal:  Vaccine       Date:  2004-09-09       Impact factor: 3.641

Review 2.  Synergy in cytokine and chemokine networks amplifies the inflammatory response.

Authors:  Mieke Gouwy; Sofie Struyf; Paul Proost; Jo Van Damme
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-14       Impact factor: 7.638

3.  Vaccine manufacturing: challenges and solutions.

Authors:  Jeffrey B Ulmer; Ulrich Valley; Rino Rappuoli
Journal:  Nat Biotechnol       Date:  2006-11       Impact factor: 54.908

Review 4.  Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.

Authors:  M L Dustin; T A Springer
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 5.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses.

Authors:  Laure Perrin-Cocon; Sophie Agaugué; Frédéric Coutant; Pierre Saint-Mézard; Aurélie Guironnet-Paquet; Jean-François Nicolas; Patrice André; Vincent Lotteau
Journal:  Vaccine       Date:  2005-09-30       Impact factor: 3.641

7.  Mature dendritic cell generation promoted by lysophosphatidylcholine.

Authors:  Frédéric Coutant; Laure Perrin-Cocon; Sophie Agaugué; Thierry Delair; Patrice André; Vincent Lotteau
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

8.  Hydrolysis of phosphatidylcholine during LDL oxidation is mediated by platelet-activating factor acetylhydrolase.

Authors:  U P Steinbrecher; P H Pritchard
Journal:  J Lipid Res       Date:  1989-03       Impact factor: 5.922

Review 9.  Structural biology of hepatitis C virus.

Authors:  François Penin; Jean Dubuisson; Felix A Rey; Darius Moradpour; Jean-Michel Pawlotsky
Journal:  Hepatology       Date:  2004-01       Impact factor: 17.425

10.  Effects of the acute phase response on the concentration and density distribution of plasma lipids and apolipoproteins.

Authors:  V G Cabana; J N Siegel; S M Sabesin
Journal:  J Lipid Res       Date:  1989-01       Impact factor: 5.922

View more
  8 in total

1.  Egg yolk IgY: protection against rotavirus induced diarrhea and modulatory effect on the systemic and mucosal antibody responses in newborn calves.

Authors:  C Vega; M Bok; P Chacana; L Saif; F Fernandez; V Parreño
Journal:  Vet Immunol Immunopathol       Date:  2011-05-07       Impact factor: 2.046

2.  Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine.

Authors:  Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Inflamm Res       Date:  2012-01-18       Impact factor: 4.575

3.  Effects of Lysophosphatidylcholine on Jejuna Morphology and Its Potential Mechanism.

Authors:  Xiaofeng Li; Abdel-Moneim Eid Abdel-Moneim; Noura M Mesalam; Bing Yang
Journal:  Front Vet Sci       Date:  2022-06-20

4.  Prospective Analysis of Lipid Composition Changes with Antiretroviral Therapy and Immune Activation in Persons Living with HIV.

Authors:  Martha A Belury; Emily Bowman; Janelle Gabriel; Brandon Snyder; Manjusha Kulkarni; Marilly Palettas; Xiaokui Mo; Jordan E Lake; David Zidar; Scott F Sieg; Benigno Rodriguez; Martin P Playford; Adriana Andrade; Daniel R Kuritzkes; Nehal N Mehta; Michael M Lederman; Nicholas T Funderburg
Journal:  Pathog Immun       Date:  2017-10-06

5.  A new passive immune strategy based on IgY antibodies as a key element to control neonatal calf diarrhea in dairy farms.

Authors:  Celina Guadalupe Vega; Marina Bok; Maren Ebinger; Lucía Alejandra Rocha; Alejandra Antonella Rivolta; Valeria González Thomas; Pilar Muntadas; Ricardo D'Aloia; Verónica Pinto; Viviana Parreño; Andrés Wigdorovitz
Journal:  BMC Vet Res       Date:  2020-07-29       Impact factor: 2.741

6.  Geniposide Ameliorates Liver Fibrosis Through Reducing Oxidative Stress and Inflammatory Respose, Inhibiting Apoptosis and Modulating Overall Metabolism.

Authors:  Lu Yang; Liping Bi; Lulu Jin; Yuming Wang; Yuting Li; Zixuan Li; Wenju He; Huantian Cui; Jing Miao; Li Wang
Journal:  Front Pharmacol       Date:  2021-11-24       Impact factor: 5.810

7.  Treatment With Lipopolysaccharide Induces Distinct Changes in Metabolite Profile and Body Weight in 129Sv and Bl6 Mouse Strains.

Authors:  Maria Piirsalu; Egon Taalberg; Kersti Lilleväli; Li Tian; Mihkel Zilmer; Eero Vasar
Journal:  Front Pharmacol       Date:  2020-03-27       Impact factor: 5.810

8.  An integrated transcriptomics and metabolomics study of the immune response of newly hatched chicks to the cytosine-phosphate-guanine oligonucleotide stimulation.

Authors:  Djomangan Adama Ouattara; Lydie Remolue; Jérémie Becker; Magali Perret; Andrei Bunescu; Kristin Hennig; Emeline Biliaut; Annemanuelle Badin; Cesarino Giacomini; Frédéric Reynier; Christine Andreoni; Frédéric Béquet; Patrick Lecine; Karelle De Luca
Journal:  Poult Sci       Date:  2020-07-02       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.